ClinicalTrials.gov
ClinicalTrials.gov Menu

The Lolland-Falster Health Study (LOFUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02482896
Recruitment Status : Recruiting
First Posted : June 26, 2015
Last Update Posted : October 7, 2016
Sponsor:
Collaborators:
Lolland Municipality, Denmark
Guldborgsund Municipality, Denmark
Information provided by (Responsible Party):
Region Sjælland

Brief Summary:
The study is a epidemiological, cross-sectional study in a mainly rural area of Denmark in Denmark. Life expectancy is shorter, morbidity is higher, and social problems more prevalent than in the urban areas of the country. The population study aims at examining complexities of environmental, hereditary, lifestyle, and social factors as determinants and predisposing factors for morbidity, health, and quality of life. The study will cover physical, mental, and social dimensions and examine family patterns and subgroups. The study will provide baseline information for later follow-up.

Condition or disease
Impaired Health Disease Wellbeing Mental Disorders Atherosclerosis Renal Insufficiency, Chronic Skin Diseases Urinary Incontinence Personality Coronary Disease Ear Diseases Nose Diseases Pharyngeal Diseases Chronic Disease

Study Type : Observational
Estimated Enrollment : 25000 participants
Observational Model: Family-Based
Time Perspective: Cross-Sectional
Official Title: The Lolland-Falster Health Study
Study Start Date : February 2016
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019



Primary Outcome Measures :
  1. Health [ Time Frame: Cross-sectional, measured once ]
    Self-administered questionnaires, clinical examination, and biospecimen


Secondary Outcome Measures :
  1. Morbidity [ Time Frame: Cross-sectional, measured once ]
    Self-administered questionnaires, clinical examination, and biospecimen

  2. Risk factors [ Time Frame: Cross-sectional, measured once ]
    Self-administered questionnaires, clinical examination, and biospecimen


Biospecimen Retention:   Samples With DNA
Blood, urine, faeces, saliva


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 110 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
The population of Lolland and Guldborgsund municipalities in Denmark.
Criteria

Inclusion Criteria:

  • Individuals registered in Lolland or Guldborgsund municipality

Exclusion Criteria:

  • Adults with incapacity guardianship
  • Incapacity to give informed consent
  • Individuals with address protection
  • Severe physical immobility
  • Non-Danish and Non-English speaking

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02482896


Contacts
Contact: Randi Jepsen, PhD, MSc, RN +4556516856 rjep@regionsjaelland.dk

Locations
Denmark
The Lolland-Falster Health Study Recruiting
Nykøbing Falster, Region Sjaelland, Denmark, 4800
Contact: Randi Jepsen, Ph.d.    +4556516856    rjep@regionsjaelland.dk   
Contact: Birgitte Lundberg, MSc    +4556516858    blun@regionsjaelland.dk   
Sponsors and Collaborators
Region Sjælland
Lolland Municipality, Denmark
Guldborgsund Municipality, Denmark
Investigators
Principal Investigator: Knud Rasmussen, Dr. Med., MD Region Sjælland

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Region Sjælland
ClinicalTrials.gov Identifier: NCT02482896     History of Changes
Other Study ID Numbers: SJ-421
First Posted: June 26, 2015    Key Record Dates
Last Update Posted: October 7, 2016
Last Verified: June 2016

Additional relevant MeSH terms:
Atherosclerosis
Urinary Incontinence
Enuresis
Coronary Disease
Coronary Artery Disease
Renal Insufficiency
Chronic Disease
Mental Disorders
Psychotic Disorders
Skin Diseases
Renal Insufficiency, Chronic
Ear Diseases
Pharyngeal Diseases
Nose Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Urination Disorders
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Signs and Symptoms
Behavioral Symptoms
Elimination Disorders
Myocardial Ischemia
Heart Diseases
Kidney Diseases
Disease Attributes
Pathologic Processes